Letter of mission from Mr. Nicolas Sarkozy, President of the Republic, addressed to Mr. Joël Menard, professor of public health, former Director General of Health, on the priorities of the Alzheimer Plan, August 1, 2007.

France Nicolas Sarkozy · President of France

1 August 2007

Context
Sarkozy addressed Professor Joël Ménard in a formal letter of mission commissioning the development of a national Alzheimer Plan, dated August 1, 2007.
Main themes
Alzheimer's disease national plan, medical research coordination, patient care quality, caregiver support, public-private research partnerships, territorial equity of care, diagnosis and treatment advancement, dependency and end-of-life issues, healthcare system mobilization, evaluation of outcomes
Duration
~7 min
22nd percentile
Words
793
22nd percentile
Sentences
42
27th percentile
Readability
33
22nd percentile
Grade
13.3
60th percentile
Syntax
2.77
19th percentile
Vocabulary
2.30
74th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 52%52%
  • Institutional 29%29%
  • Ceremonial 14%14%
  • Economic 5%5%
  • Geopolitical 0%0%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

42 sentences in 18 paragraphs

Professor,

Alzheimer's disease, which today affects 860,000 people in France, is a tragedy for our society, a family tragedy. Every year, there are 225,000 new cases diagnosed in France, causing much suffering and distress for both the person afflicted by the disease and their loved ones. In the coming years, the human and financial costs of the disease, which are already high for both families and society, will continue to increase.

Recently, efforts have been made. Research groups have made significant contributions using multiple techniques in genetics, biochemistry, anatomical pathology, imaging, experimental pathology, clinical investigation, therapeutic trials, and epidemiological studies, all necessary to advance knowledge and treatment in this field. The healthcare system has been mobilized through the creation of Memory Resource and Research Centers and by efforts to structure geriatrics. Finally, the social and medico-social approach has been developed at the departmental level to support patients and their families.

However, these initial efforts are not enough. It is essential that the numerous and promising research avenues ultimately lead to results. The real effort that the nation dedicates to this cause must be assessed in comparison with what is being done in other countries. It is then necessary to alleviate the various forms of suffering, of which dementia in the elderly is just one component, and to ensure that the support provided to patients is consistent throughout the territory. Finally, it is essential that the attitude of French society towards dependency and end-of-life issues in general evolves.

I have therefore decided to launch an ambitious Alzheimer Plan to better understand, diagnose, and manage the disease. Its development will be carried out under the auspices of a commission, of which I entrust you with the presidency.

The Alzheimer Plan that you will build will have a dual priority. First, it must enable the unification of research efforts to promote the discovery in France of a validated diagnosis and an indisputably effective treatment. Second, this Plan must improve the quality of care for patients. When the disease sets in, each patient and each family must be able to find an appropriate mode of care.

In this perspective, the commission you will preside over must examine the conditions under which French research efforts can be optimized within the context of a global research system that has its own dynamics, both predictable through techniques and modes of reasoning, and unpredictable through discoveries. You will reflect on the best way to structure partnerships between the public and private sectors. New coordinations need to be established, facilitated, and evaluated.

You will ensure that the objectives of research, care, and management are defined in parallel. Constant links between these three objectives must be established to accelerate both the transfer of research progress to the healthcare system and the transfer of field observations to technological, biological, psychological, and social research. In the development of the Plan, you will therefore prioritize the continuity from research to care. Access to care must be seamless, and clinical research must be carefully coupled with care at selected sites based on quality and organizational criteria.

You will also pay close attention to the continuity and territorial equity of care for patients and their families at all stages of cognitive and relational function impairment. The essential role of families and caregivers who assist individuals with altered behavioral and cognitive functions, whether through discreet help or total dependency care, must be recognized.

In the proposals you will be led to formulate, I ask you to pay particular attention to the continuous evaluation of results. This Plan will only have a real impact if we avoid certain mistakes of the past. Major national actions have sometimes yielded positive results, but with poorly measured efficiency.

Finally, I wish for all actors already involved in various fundamental and clinical research structures, both public and private, and in the establishments and associations caring for patients, to be mobilized on this national issue, as well as society as a whole.

The commission you will rely on will call upon actors involved in the health and medico-social sectors and responsible officials from the relevant administrations. It will surround itself with appropriate technical groups to take stock based on the analyses already available, propose objectives, select indicators, and estimate costs. The appropriate resources will be made available to you so that the quality of your commission's work meets the expectations expressed.

The Alzheimer Plan that I ask you to present must be ready by November 1, 2007, for implementation at the beginning of 2008. The initial orientations of the Plan must be outlined by September 21, the date of World Alzheimer's Day.

Please accept, Professor, the assurance of my highest consideration.

Nicolas SARKOZY

Mr. Jöel MENARD

Professor of Public Health

Former Director General of Health